Arcus Biosciences, Inc. (RCUS)
29.21
-1.38
(-4.51%)
USD |
NYSE |
Aug 28, 16:00
29.18
-0.03
(-0.10%)
After-Hours: 20:00
Arcus Biosciences Total Return Price : 29.21 for Aug. 28, 2026
Total Return Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Price Data
| Date | Value |
|---|---|
| August 28, 2026 | 29.21 |
| August 27, 2026 | 30.59 |
| August 26, 2026 | 30.76 |
| August 25, 2026 | 31.57 |
| August 24, 2026 | 30.12 |
| August 21, 2026 | 30.34 |
| August 20, 2026 | 29.52 |
| August 19, 2026 | 30.35 |
| August 18, 2026 | 29.51 |
| August 17, 2026 | 29.56 |
| August 14, 2026 | 29.48 |
| August 13, 2026 | 28.86 |
| August 12, 2026 | 28.96 |
| August 11, 2026 | 28.74 |
| August 10, 2026 | 28.72 |
| August 07, 2026 | 28.62 |
| August 06, 2026 | 28.33 |
| August 05, 2026 | 27.70 |
| August 04, 2026 | 28.80 |
| August 03, 2026 | 27.62 |
| July 31, 2026 | 28.19 |
| July 30, 2026 | 28.25 |
| July 29, 2026 | 26.45 |
| July 28, 2026 | 27.05 |
| July 27, 2026 | 27.84 |
| Date | Value |
|---|---|
| July 24, 2026 | 28.42 |
| July 23, 2026 | 29.73 |
| July 22, 2026 | 29.97 |
| July 21, 2026 | 29.48 |
| July 20, 2026 | 28.17 |
| July 17, 2026 | 27.37 |
| July 16, 2026 | 26.64 |
| July 15, 2026 | 28.02 |
| July 14, 2026 | 28.33 |
| July 13, 2026 | 28.07 |
| July 10, 2026 | 28.92 |
| July 09, 2026 | 29.96 |
| July 08, 2026 | 30.26 |
| July 07, 2026 | 30.25 |
| July 06, 2026 | 29.98 |
| July 02, 2026 | 30.33 |
| July 01, 2026 | 28.92 |
| June 30, 2026 | 30.83 |
| June 29, 2026 | 31.08 |
| June 26, 2026 | 31.00 |
| June 25, 2026 | 30.25 |
| June 24, 2026 | 28.80 |
| June 23, 2026 | 28.18 |
| June 22, 2026 | 27.23 |
| June 18, 2026 | 24.31 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| Halozyme Therapeutics, Inc. | 105.35 |
| AVITA Medical, Inc. | 10.35 |
| Iovance Biotherapeutics, Inc. | 8.01 |
| Editas Medicine, Inc. | 3.16 |
| Recursion Pharmaceuticals, Inc. | 3.34 |